Article

Clinicopathological Features of KRAS-Mutated Colon Cancer: An Analytical Cross-Sectional Study

2024-08-27

Abstract excerpt

<title>Abstract</title> <p>Background Colon cancer is a leading neoplasm worldwide, with 35–45% of colorectal cancer patients exhibiting mutations in the Kirsten rat sarcoma oncogene (KRAS). This mutation affects disease development and serves as a biomarker for early detection, prognosis, and treatment. Objective Identify the clinicopathological characteristics of colon cancer patients with KRAS mutations. Mat...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: a72c1d6e-de04-5517-84d6-2f1a9164408a
DOI: 10.21203/rs.3.rs-4797625/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Clinicopathological Features of KRAS-Mutated Colon Cancer: An Analytical Cross-Sectional StudyDOI 10.21203/rs.3.rs-4797625/v1Read

The Impact of KRAS Mutation on the Presentation and Prognosis of Non-Metastatic Colon Cancer: an Analysis from the National Cancer Database.Semantic proximity Read

Relationship Between KRAS Gene Mutation Status and Clinicopathological Features of Colorectal Cancer Patients in MakassarSemantic proximity Read

BRAF Mutated Colorectal Cancer: New Treatment ApproachesSemantic proximity Read

Patient and tumor characteristics and BRAF and KRAS mutations in colon cancer, NCCTG/Alliance N0147.Semantic proximity Read

Prevalence of colorectal cancer biomarkers and their impact on clinical outcomes in Riyadh, Saudi Arabia.Semantic proximity Read

The association of clinicopathological features and survival in colorectal cancer patients with kras mutation status.Semantic proximity Read

Role of oncogenic KRAS in the prognosis, diagnosis and treatment of colorectal cancer.Semantic proximity Read

Clinicopathological Features and Survival Rate of Colorectal Adenocarcinoma Patients with and without a KRAS Mutation: a FiveYear Study in Yazd, Iran.Semantic proximity Read

Prognostic and Predictive Roles of KRAS Mutation in Colorectal CancerSemantic proximity Read

KRAS Testing, Tumor Location, and Survival in Patients With Stage IV Colorectal Cancer: SEER 2010-2013.Semantic proximity Read

Association between clinicopathological characteristics and RAS mutation in colorectal cancer.Semantic proximity Read

Oncogenic mutations and microsatellite instability phenotype predict specific anatomical subsite in colorectal cancer patients.Semantic proximity Read